•  
  •  
  •  
  •  

2025-11-04 05:21:58

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Fabtech Technologies Limited Secures Rs. 52 Crore Contract
  • Power Grid Corporation of India Ltd declares interim dividend of Rs. 4.50
  • Kulin Lalbhai elevated as Chairman of Arvind SmartSpaces Limited
  • Lords Chloro Alkali Ltd enters into lease agreement
  • Tolins Tyres Secures IRT Rate Contract for Supply to Tamil Nadu State Transport Undertakings

Keywords Selected:  Liraglutide

Stock Report

  • Lupin Launches Liraglutide Injection in the United States
  • Lupin receives US FDA Approvals for Liraglutide and Glucagon Injectable Products
  • Biocon Limited launches its Glucagon-like peptide-1 (GLP -1), Liraglutide, in the United Kingdom
  • Biocon Ltd signs semi-exclusive distribution and supply deal for the commercialization of generic Saxenda® in Mexico with Medix
  • Biocon's European partner Zentiva receives approval from UK MHRA for Liraglutide
  • Biocon is the first generics Company to obtain approval for diabetes drug, Liraglutide, in the U.K.
  • Glenmark is the first to launch Biosimilar of Popular Anti‐Diabetic Drug, Liraglutide, in India
  • Biocon Limited enters into a commercialization agreement with Zentiva in Europe

Latest Post

  • Fabtech Technologies Limited Secures Rs. 52 Crore Contract
  • Power Grid Corporation of India Ltd declares interim dividend of Rs. 4.50
  • Kulin Lalbhai elevated as Chairman of Arvind SmartSpaces Limited
  • Lords Chloro Alkali Ltd enters into lease agreement
  • Tolins Tyres Secures IRT Rate Contract for Supply to Tamil Nadu State Transport Undertakings


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024